Henry Zecca

Discovery of Tetrahydropyridopyrimidines as Irreversible Covalent Inhibitors of KRAS-G12C with In Vivo Activity.

J. Blake, J. Christensen, B. Brandhuber, 2018, ACS medicinal chemistry letters.

Novel 1,2-dihydroquinazolin-2-ones: Design, synthesis, and biological evaluation against Trypanosoma brucei.

F. Gamarro, D. González-Pacanowska, C. Butler, 2017, Bioorganic & medicinal chemistry letters.

Screening and Development of Constitutively Synergistic Combination Drug Formulations for T Cell Acute Lymphoblastic Leukemia

Melissa L. Kemp, W. Lam, H. Fu, 2022, bioRxiv.

Constitutively synergistic multiagent drug formulations targeting MERTK, FLT3, and BCL-2 for treatment of AML

H. Fu, Yuhong Du, S. Moore, 2023, bioRxiv.

Development of constitutively synergistic nanoformulations to enhance chemosensitivity in T-cell leukemia.

Melissa L. Kemp, W. Lam, H. Fu, 2023, Journal of controlled release : official journal of the Controlled Release Society.

Constitutively Synergistic Multiagent Drug Formulations Targeting MERTK, FLT3, and BCL-2 for Treatment of AML

Xiaodong Wang, Yuhong Du, D. DeRyckere, 2023, Pharmaceutical Research.